Free Cash Flow
Keros Therapeutics, Inc. (KROS)
$49.17
+1.37 (+2.87%)
Free Cash Flow
Year A/P |
| Revenue |
|---|
| Revenue (%) |
| Operating Cash Flow |
| Operating Cash Flow (%) |
| Capital Expenditure |
| Capital Expenditure (%) |
| Free Cash Flow |
FCF Unlevered from cash flow statement